Effects of monoglucosyl hesperidin on human lymphatic circulatory function: A randomized placebo-controlled, double-blind, crossover trial

Akira Shinaoka, Takayuki Honjo, Kyoko Takata, Yukie Karasudani, Shigeo Moriguchi, Yasuhiro Tanaka, Hisako Minami, Toshihiro Maekawa, Akifumi Maeda, Yoshihiro Kimata · 2026

Read Effects of monoglucosyl hesperidin on human lymphatic circulatory function: A randomized placebo-controlled, double-blind, crossover trial by Akira Shinaoka, Takayuki Honjo, Kyoko Takata, Yukie Karasudani, Shigeo Moriguchi, Yasuhiro Tanaka, Hisako Minami, Toshihiro Maekawa, Akifumi Maeda, Yoshihiro Kimata (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13253825.txt.

Description

Akira Shinaoka and co-authors test a citrus compound on lymph flow in a 2026 trial. Monoglucosyl hesperidin, from citrus peel, aids blood flow and cuts swelling in earlier work. Thirty healthy adults took 300 milligrams a day or a placebo, swapping over in a crossover design, while scans measured the main lymph duct.

No effect showed in the full group. Among people with no exercise habit, though, the duct widened clearly after intake, matching higher lymph flow seen in animal studies. The authors also propose duct scans as a painless marker for future lymph studies.

Catalog record

CREATORAkira Shinaoka, Takayuki Honjo, Kyoko Takata, Yukie Karasudani, Shigeo Moriguchi, Yasuhiro Tanaka, Hisako Minami, Toshihiro Maekawa, Akifumi Maeda, Yoshihiro Kimata
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42102
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13253825

Browse the full library · About the Tower of Babel